To investigate the prognostic value of CCDC170, IRE1α and XBP1s in breast cancer, we used immunohistochemistry to assess the expression of these proteins in 100 patients with invasive ductal carcinoma. This evidence concerns the gene ERN1 and breast carcinoma.